| Ann Marie Shaughnessy, PTA | |
|
10034 W 151st St, Overland Park, KS 66221-9326 | |
| (913) 257-5425 | |
| Not Available |
| Full Name | Ann Marie Shaughnessy |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 10034 W 151st St, Overland Park, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487393195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 14-03124 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ann Marie Shaughnessy, PTA 643 Splitlog Ave, Kansas City, KS 66101-3331 Ph: (816) 673-6933 | Ann Marie Shaughnessy, PTA 10034 W 151st St, Overland Park, KS 66221-9326 Ph: (913) 257-5425 |
News Archive
In the spring, later sunset and extended daylight exposure delay bedtimes in teenagers, according to researchers at Rensselaer Polytechnic Institute's Lighting Research Center (LRC).Biologically, this increased exposure to early evening light in the spring delays the onset of nocturnal melatonin, a hormone that indicates to the body when it's nighttime, explains Mariana Figueiro, Ph.D., associate professor. This extended exposure adds to the difficulties teens have falling asleep at a reasonable hour.
BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.
Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that it has participated in a U.S. $3 million financing round of Avraham Pharmaceuticals Ltd. together with Pontifax, Clal Biotechnology Industries (CBI), Technion Research and Development Foundation Ltd. (TRDF), Professor Marta Weinstock-Rosin and others.
Sanofi-aventis announced today a strategic alliance agreement with the Massachusetts Institute of Technology Center for Biomedical Innovation, which will be known as the sanofi-aventis Biomedical Innovation Program.
› Verified 3 days ago
Dr. Michael Jonathan Khadavi, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10777 Nall Ave Ste 300, Overland Park, KS 66211 Phone: 913-642-0200 Fax: 913-563-6699 | |
James Sigler, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 210, Overland Park, KS 66211 Phone: 913-558-0058 Fax: 913-871-6412 | |
Dr. Ira Hartley Fishman, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 10520 Barkley St, Suite 120, Overland Park, KS 66212 Phone: 913-341-0090 Fax: 913-341-0091 | |
Jennifer E. Finley, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 10770 El Monte St, Suite 102, Overland Park, KS 66211 Phone: 913-681-1620 Fax: 913-383-1608 | |
Joseph F Galate, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10777 Nall Ave, Suite 120, Overland Park, KS 66211 Phone: 913-387-2800 Fax: 913-387-2970 | |
Deborah Ruggles, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 10701 Nall Ave, Suite 200, Overland Park, KS 66211 Phone: 913-341-5225 Fax: 913-901-0186 | |
Atul T Patel, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10701 Nall Ave, Suite 200, Overland Park, KS 66211 Phone: 913-381-5225 Fax: 913-901-0186 |